WASHINGTON (Reuters) – Sanofi said on Monday it was terminating a deal to exclusively license a drug that Maze Therapeutics is developing to treat Pompe disease because of objections from …
sanofi
-
-
(Reuters) – Paris-based drugmaker Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics, Bloomberg News reported on Thursday citing people familiar with the matter. Deliberations are ongoing and …
-
By Ludwig Burger (Reuters) -French drugmaker Sanofi on Friday increased its guidance for full-year earnings, citing strong sales of anti-inflammatory treatment Dupixent and closely-watched new drug launches. The Paris-based drugmaker …
-
(Reuters) -Amgen Inc is in advanced talks to buy biotech company Horizon Therapeutics Plc, the Wall Street Journal reported on Sunday, while rival bidder French health group Sanofi announced it …
-
PARIS (Reuters) – Healthcare companies Sanofi and partner Regeneron presented on Tuesday more positive data for their Dupixent product. The companies said new data showed that Dupixent showed a significant …
-
PARIS (Reuters) -French drugmaker Sanofi said it expected a positive boost to its third-quarter business results from movements on the currency markets, helped by the strength of the U.S. dollar …
-
By Ludwig Burger FRANKFURT (Reuters) – Sanofi’s recent stock rout underscores the pressure on the French drug maker to redouble its efforts in the hunt for new medicines. Chief Executive …
-
FRANKFURT (Reuters) – Sanofi’s finance chief said on Wednesday that a decline in the French company’s share price in response to litigation threats and a cancer drug development setback was …
-
(Reuters) – Innovent Biologics Inc said on Friday Paris-based Sanofi SA would invest HK$2.42 billion ($307.88 million) in the biopharmaceutical group to jointly develop two cancer drugs in China. The …
-
(Reuters) – French drugmaker Sanofi said on Wednesday uninsured diabetes patients in the United States will pay no more than $35 for 30-day supply of insulin, in the wake of …
-
PARIS – A French court has ordered Sanofi to pay more than 400,000 euros ($416,440) in damages to a family whose child suffered from a form of autism caused by …
-
(Reuters) – French healthcare group Sanofi said it had priced a first sustainability-linked bond issue that will be indexed on access to medicines, and worth 1.5 billion euros ($1.7 billion). …
-
PARIS – French drugmaker Sanofi on Wednesday said it would stop immediately any new spending not related to the supply of essential and life-changing medicines and vaccines in Russia, as …
-
By Mathieu Rosemain PARIS – Drugmaker Sanofi is investing $180 million in French startup Owkin, whose predictive algorithms aim to improve the research and development of new cures against cancer, …